Novel Perspectives in Pseudomyxoma Peritonei Treatment

SIMPLE SUMMARY: Pseudomyxoma Peritonei (PMP) represents a rare entity which greatly benefits from Cytoreductive Surgery (CRS) associated with Hyperthermic Intraperitoneal Chemotherapy (HIPEC). In fact, CRS-HIPEC represents the treatment with potential chances of cure and long-term disease control of...

Descripción completa

Detalles Bibliográficos
Autores principales: Sommariva, Antonio, Tonello, Marco, Rigotto, Giulia, Lazzari, Nayana, Pilati, Pierluigi, Calabrò, Maria Luisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656832/
https://www.ncbi.nlm.nih.gov/pubmed/34885075
http://dx.doi.org/10.3390/cancers13235965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656832/
https://www.ncbi.nlm.nih.gov/pubmed/34885075
http://dx.doi.org/10.3390/cancers13235965

Ejemplares similares